Skip to Content

LET 2.5 (Letrozole 2.5 mg)

Pill with imprint LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Dr. Reddy's Laboratories Limited .

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LET 2.5

Letrozole

Imprint
LET 2.5
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Limited
National Drug Code (NDC)
55111-0646
Inactive Ingredients
silicon dioxide colloidal, croscarmellose sodium, hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "LET 2.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.